These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35038906)

  • 41. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
    Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
    Garcia G; Sharma A; Ramaiah A; Sen C; Purkayastha A; Kohn DB; Parcells MS; Beck S; Kim H; Bakowski MA; Kirkpatrick MG; Riva L; Wolff KC; Han B; Yuen C; Ulmert D; Purbey PK; Scumpia P; Beutler N; Rogers TF; Chatterjee AK; Gabriel G; Bartenschlager R; Gomperts B; Svendsen CN; Betz UAK; Damoiseaux RD; Arumugaswami V
    Cell Rep; 2021 Apr; 35(1):108940. PubMed ID: 33784499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
    Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
    Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication.
    Ma-Lauer Y; Li P; Niemeyer D; Richter A; Pusl K; von Brunn B; Ru Y; Xiang C; Schwinghammer S; Liu J; Baral P; Berthold EJ; Qiu H; Roy A; Kremmer E; Flaswinkel H; Drosten C; Jin Z; von Brunn A
    Front Cell Infect Microbiol; 2024; 14():1383917. PubMed ID: 39119292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
    Varghese FS; van Woudenbergh E; Overheul GJ; Eleveld MJ; Kurver L; van Heerbeek N; van Laarhoven A; Miesen P; den Hartog G; de Jonge MI; van Rij RP
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA.
    Yamasaki M; Saso W; Yamamoto T; Sato M; Takagi H; Hasegawa T; Kozakura Y; Yokoi H; Ohashi H; Tsuchimoto K; Hashimoto R; Fukushi S; Uda A; Muramatsu M; Takayama K; Maeda K; Takahashi Y; Nagase T; Watashi K
    Antiviral Res; 2024 Oct; 230():105992. PubMed ID: 39181215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2.
    Villalobos-Sánchez E; García-Ruiz D; Camacho-Villegas TA; Canales-Aguirre AA; Gutiérrez-Ortega A; Muñoz-Medina JE; Elizondo-Quiroga DE
    Viruses; 2023 May; 15(5):. PubMed ID: 37243241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
    Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production.
    Fintelman-Rodrigues N; Sacramento CQ; Ribeiro Lima C; Souza da Silva F; Ferreira AC; Mattos M; de Freitas CS; Cardoso Soares V; da Silva Gomes Dias S; Temerozo JR; Miranda MD; Matos AR; Bozza FA; Carels N; Alves CR; Siqueira MM; Bozza PT; Souza TML
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32759267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue.
    Stasko N; Kocher JF; Annas A; Henson I; Seitz TS; Miller JM; Arwood L; Roberts RC; Womble TM; Keller EG; Emerson S; Bergmann M; Sheesley ANY; Strong RJ; Hurst BL; Emerson D; Tarbet EB; Bradrick SS; Cockrell AS
    Sci Rep; 2021 Oct; 11(1):20595. PubMed ID: 34663881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitors of Anti-apoptotic Bcl-2 Family Proteins Exhibit Potent and Broad-Spectrum Anti-mammarenavirus Activity via Cell Cycle Arrest at G0/G1 Phase.
    Kim YJ; Witwit H; Cubitt B; de la Torre JC
    J Virol; 2021 Nov; 95(24):e0139921. PubMed ID: 34586865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation.
    Lim YS; Nguyen LP; Lee GH; Lee SG; Lyoo KS; Kim B; Hwang SB
    Mol Cells; 2021 Sep; 44(9):688-695. PubMed ID: 34518443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. R-Propranolol Has Broad-Spectrum Anti-Coronavirus Activity and Suppresses Factors Involved in Pathogenic Angiogenesis.
    Thaler M; Salgado-Benvindo C; Leijs A; Tas A; Ninaber DK; Arbiser JL; Snijder EJ; van Hemert MJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells.
    Dinesh Kumar N; Ter Ellen BM; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; van Gosliga D; Apperloo L; Carpaij OA; van den Berge M; Nawijn MC; Stienstra Y; Rodenhuis-Zybert IA; Smit JM
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0154321. PubMed ID: 34633839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
    Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
    J Virol; 2021 May; 95(12):. PubMed ID: 33789998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiviral Effect of Budesonide against SARS-CoV-2.
    Heinen N; Meister TL; Klöhn M; Steinmann E; Todt D; Pfaender S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.